Corcept Therapeutics
CORT
#2478
Rank
NZ$9.93 B
Marketcap
$94.82
Share price
-0.56%
Change (1 day)
120.77%
Change (1 year)

P/E ratio for Corcept Therapeutics (CORT)

P/E ratio as of November 2024 (TTM): 63.7

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 63.7386. At the end of 2022 the company had a P/E ratio of 21.4.

P/E ratio history for Corcept Therapeutics from 2004 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202221.44.74%
202120.4-28.21%
202028.495.05%
201914.6-29.07%
201820.628.6%
201716.0-84.63%
2016104-246.14%
2015-71.1635.14%
2014-9.6838.68%
2013-6.98100.08%
2012-3.49-59.21%
2011-8.55-13.61%
2010-9.9035.29%
2009-7.32208.41%
2008-2.37-73.9%
2007-9.09705.38%
2006-1.13-72.79%
2005-4.15-40.94%
2004-7.02

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
10.9-82.95%๐Ÿ‡บ๐Ÿ‡ธ USA
14.6-77.13%๐Ÿ‡บ๐Ÿ‡ธ USA
27.6-56.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
139 117.71%๐Ÿ‡บ๐Ÿ‡ธ USA
13.4-78.96%๐Ÿ‡บ๐Ÿ‡ธ USA
53.5-16.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.8546-101.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-36.2-156.81%๐Ÿ‡บ๐Ÿ‡ธ USA
80.3 26.05%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.